HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Marshall D. Kramer Peter X. Adams Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flum, D. R. Articles by Wallack, M. K. Search for Related Content PubMed PubMed Citation Articles by Flum, D. R. Articles by Wallack, M. K.

J Thorac Cardiovasc Surg 1997;114:361-366
© 1997 Mosby, Inc.

GENERAL THORACIC SURGERY

THORACOSCOPY IN ACQUIRED IMMUNODEFICIENCY SYNDROME

Received for publication Jan. 10, 1997; revisions requested April 7, 1997; revisions received May 5, 1997; accepted for publication May 6, 1997. Address for reprints: David R. Flum, MD, 130 West 12th St., 11G, New York, NY 10011.

Abstract

Objective: The role of thoracic surgery in patients with acquired immunodeficiency syndrome (AIDS) continues to evolve. This review seeks to evaluate the outcome, morbidity, and mortality associated with videoassisted thoracoscopic surgery for empyema and pneumothorax in patients with AIDS. Methods: A retrospective review was conducted of patients with AIDS in whom video-assisted thoracoscopic surgery was performed for empyema (group 1) or intractable pneumothorax (group 2). Results: Twenty patients with AIDS (95% male, mean age 37.4 years, mean CD4 count 76 cells/ml³) underwent thoracoscopy. Surgery was performed for empyema (group 1) in 11 (55%) and intractable pneumothorax (group 2) in nine (45%). Three patients (15%) died within 30 days of the operation. At mean follow-up (29 months), overall survival was 55%. For those who survived the hospitalization and died within the follow-up period (35.3%), mean survival time was 8.2 months (range 1 month to 27 months). In group 1, surgical procedures were performed after 8 days of chest tube drainage and included pleural debridement and mechanical pleurodesis (n = 11) along with lung biopsy (n = 6). Survivals at 30 days and 29 months' follow-up were 90.9% and 45.4%, respectively. In group 2, significantly depressed CD4 counts (average 33.2 cells/ml³) were noted along with a more prolonged preoperative hospitalization (18.5 days) with 14.2 days spent with a chest tube before the operation. In this group, operative procedures included mechanical pleurodesis and talc poudrage (n = 9), bleb resection (n = 7), and lung biopsy (n = 1). Two deaths (22%) occurred within 30 days of the operation and survival at 29 months' follow-up was 66% Conclusion: Video-assisted thoracoscopic surgery performed in patients with AIDS for the treatment of empyema and intractable pneumothorax is effective, can be performed with little operative morbidity and mortality, and is associated with acceptable long-term survival. Video-assisted thoracoscopic surgery is best performed soon after the diagnosis of intractable pneumothorax or empyema has been established.

This article has been cited by other articles:

				B. Afessa Pleural Effusion and Pneumothorax in Hospitalized Patients With HIV Infection: The Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients With HIV (PIP) Study Chest, April 1, 2000; 117(4): 1031 - 1037. [Abstract] [Full Text] [PDF]